Related Experiment Video

Updated: May 17, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Synthetic lethal interactions between EGFR and PARP inhibition in human triple negative breast cancer cells

Somaira Nowsheen1, Tiffiny Cooper, Jennifer A Stanley

  • 1Department of Radiation Oncology, Comprehensive Cancer Center, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama, United States of America.

Plos One
|October 17, 2012
PubMed

Insights

Combined inhibition of EGFR and PARP shows promise for aggressive triple-negative breast cancer (TNBC). This approach induces DNA damage and apoptosis, offering a potential new therapeutic strategy for TNBC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Therapeutics

Background:

  • Triple-negative breast cancer (TNBC) is an aggressive subtype with limited treatment options.
  • EGFR and PARP are key targets in cancer therapy, but their combined role in TNBC is not fully understood.

Purpose of the Study:

  • To investigate the efficacy and mechanism of combined EGFR and PARP inhibition in TNBC.
  • To explore the potential for synthetic lethality through this combination therapy.

Main Methods:

  • In vitro and in vivo studies using lapatinib (EGFR inhibitor) and ABT-888 (PARP inhibitor).
  • Analysis of DNA double-strand break repair, apoptosis pathways, and protein complex formation (EGFR-BRCA1).
  • Assessment of subcellular localization of EGFR and BRCA1.

Main Results:

  • Combined EGFR and PARP inhibition achieved synthetic lethality in TNBC models.
  • Lapatinib induced transient DNA double-strand break repair deficits and apoptosis.
  • Lapatinib disrupted the EGFR-BRCA1 complex and altered protein subcellular localization.

Conclusions:

  • Combined EGFR and PARP inhibition presents a novel therapeutic strategy for TNBC.
  • EGFR and BRCA1 interaction and subcellular localization play a critical role in homologous recombination repair.
  • Contextual synthetic lethality can be achieved with combined EGFR and PARP inhibitors in TNBC.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...